Elilly在印度推出Mounjaro, 一种糖尿病药物, Eli Lilly launches Mounjaro in India, a diabetes drug that also aids significant weight loss.

Elilly在印度引进了Mounjaro, 这是一种糖尿病药物, Eli Lilly has introduced Mounjaro, a diabetes drug that also promotes significant weight loss, in India. 药价为每瓶3,500至4,375英镑,价格昂贵,但在2026年引进非专利药时,价格可能更低廉。 Priced at ₹3,500 to ₹4,375 per vial, the drug is costly but could become more affordable when generics are introduced in 2026. Zerodha公司的共同创始人Nithin Kamath预测了工业的潜在影响,称食品和其他商品的消费减少。 Zerodha co-founder Nithin Kamath predicts potential industry impacts, citing reduced consumption of food and other goods. Mounjaro显示出了超过体重损失的好处,例如心理健康的改善和欲望的减少,尽管长期影响尚不得而知。 Mounjaro has shown benefits beyond weight loss, such as improved mental health and reduced cravings, though long-term effects are still unknown.